PARP Inhibitor Market Witnesses Robust Growth Amid Precision Medicine Trends
The PARP Inhibitor Market is witnessing strong expansion due to the rising global burden of cancer and increasing adoption of targeted therapies. The market was valued at approximately USD 6.81 billion in 2024 and is projected to reach USD 13.27 billion by 2033, growing at a CAGR of 8.7 percent during the forecast period. PARP inhibitors are a class of drugs used in cancer treatment,...
0 Comments 0 Shares 0 Reviews
Sponsored
Sponsored